The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)
1 other identifier
interventional
33
1 country
3
Brief Summary
This investigation is designed to evaluate the performance as well as the patients overall acceptance of the interface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2018
CompletedFirst Posted
Study publicly available on registry
October 31, 2018
CompletedStudy Start
First participant enrolled
November 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2019
CompletedFebruary 28, 2020
February 1, 2020
1.1 years
October 28, 2018
February 26, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Trial Mask usability
Questionnaire on ease-of-use (very easy to very difficult) Subjective
14 ± 4 days in home
Trial mask Performance
Questionnaire on performance (very good to very poor)- Subjective
14 ± 4 days in home
Secondary Outcomes (2)
Trial mask Reliability
5 months and 2 weeks in home
Trial mask performance measured in L/min
14 ± 4 days in home
Study Arms (1)
Arm
EXPERIMENTALF\&P Interface will be used by OSA participants in-home for 2 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Adult (18+ years of age)
- Able to give written consent
- AHI ≥ 5 on diagnostic night
- Either prescribed APAP, CPAP or Bi-level PAP for OSA
You may not qualify if:
- Inability to give written consent
- Anatomical or physiological conditions making PAP therapy inappropriate
- Commercial drivers who are investigated by New Zealand Transport Agency (NZTA)
- Current diagnosis of respiratory disease or CO2 retention
- Pregnant or may think they are pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hawkes Bay Fallen Soldiers' Memorial Hospital
Hastings, Hawkes Bay, 4120, New Zealand
Fisher & Paykel Healthcare
Auckland, 2013, New Zealand
Well Sleep
Wellington, 6035, New Zealand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bhavi Ogra
Clinical Manager
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 28, 2018
First Posted
October 31, 2018
Study Start
November 5, 2018
Primary Completion
November 30, 2019
Study Completion
November 30, 2019
Last Updated
February 28, 2020
Record last verified: 2020-02